北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Updated Follow-up and Results of Subsequent Therapy in the Phase III VISTA Trial: Bortezomib Plus Melphalan-Prednisone Versus Melphalan-Prednisone in Newly Diagnosed Multiple Myeloma
作者: Miguel, Jesus F. San1; Schlag, Rudolf2; Khuageva, Nuriet K.3; Dimopoulos, Meletios A.4; Shpilberg, Ofer5; Kropff, Martin H.6; Spicka, Ivan7; Petrucci, Maria Teresa8; Palumbo, Antonio9; Samoilova, Olga S.10; Dmoszynska, Anna11; Abdulkadyrov, Kudrat M.12; Schots, Rik13; Jiang, Bin14; Mateos, Maria-Victoria15; Anderson, Kenneth C.16; Esseltine, Dixie-Lee17; Liu, Kevin18; Cakana, Andrew19; van de Velde, Helgi19; Richardson, Paul
刊名: BLOOD
发表日期: 2008-11-16
卷: 112, 期:11, 页:242-242
收录类别: SCI
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Hematology
研究领域[WOS]: Hematology
语种: 英语
WOS记录号: WOS:000262104700651
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/58924
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.St Petersburg Clin Res Inst Hematol & Transfusiol, St Petersburg, Russia
2.Belgian Hematol Soc, Myeloma Study Grp, Brussels, Belgium
3.Peking Univ, Peoples Hosp, Beijing, Peoples R China
4.Hosp Univ Salamanca, Salamanca, Spain
5.Praxis Hematol & Oncol, Wurzburg, Germany
6.SP Botkin Moscow City Clin Hosp, Dept Hematol, Moscow, Russia
7.Rabin Med Ctr, Petah Tiqwa, Israel
8.Univ Munster, Munster, Germany
9.Charles Univ Praha, Dept Int Med 1, Prague, Czech Republic
10.Univ Roma La Sapienza, Rome, Italy
11.Med Univ Lublin, Lublin, Poland
12.Univ Turin, Div Ematol, AOU San Giovanni Battista, Turin, Italy
13.Nizhnii Novgorod Reg Clin Hosp, Nizhnii Novgorod, Russia
14.USAL, CSIC, IBMCC, CIC,Hosp Univ Salamanca, Salamanca, Spain
15.Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece
16.Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Dis Ctr, Boston, MA 02115 USA
17.Takeda Oncol Co, Millennium Pharmaceut, Cambridge, MA USA
18.Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ USA
19.Johnson & Johnson Pharmaceut Res & Dev, Dept Clin R&D Oncol, Beerse, Belgium

Recommended Citation:
Miguel, Jesus F. San,Schlag, Rudolf,Khuageva, Nuriet K.,et al. Updated Follow-up and Results of Subsequent Therapy in the Phase III VISTA Trial: Bortezomib Plus Melphalan-Prednisone Versus Melphalan-Prednisone in Newly Diagnosed Multiple Myeloma[J]. BLOOD,2008,112(11):242-242.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Miguel, Jesus F. San]'s Articles
[Schlag, Rudolf]'s Articles
[Khuageva, Nuriet K.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Miguel, Jesus F. San]‘s Articles
[Schlag, Rudolf]‘s Articles
[Khuageva, Nuriet K.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace